Iovance Biotherapeutics Inc. (IOVA) Business Metric Overview

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Iovance Biotherapeutics I... (IOVA)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

5.89

0.11 (1.90%)

At close: Jan 14, 2025, 3:59 PM

6.19

5.09%

Pre-market Jan 15, 2025, 09:05 AM EST

Iovance Biotherapeutics Inc. Revenue Breakdown

Quarter	Sep 30, 2023	Jun 30, 2023
Product Revenue	500.00K	200.00K
Product Revenue Growth	+150.00%	n/a

Revenue by Geography

Quarter	Dec 31, 2023
Non-Us Revenue	1.20M
Non-Us Revenue Growth	n/a
United States Revenue	n/a
United States Revenue Growth	n/a

Operating Expense Breakdown

Quarter	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016	Dec 31, 2015	Sep 30, 2015	Jun 30, 2015	Mar 31, 2015
Selling, General, and Administrative Revenue	39.55M	34.19M	26.12M	20.19M	26.96M	21.93M	28.12M	26.46M	27.89M	26.33M	23.41M	23.85M	20.89M	19.31M	19.62M	16.08M	15.92M	14.35M	13.86M	10.87M	10.03M	10.87M	9.08M	7.53M	7.11M	6.83M	6.96M	5.38M	4.59M	3.93M	4.26M	5.02M	10.50M	7.26M	2.82M	3.93M	2.66M	2.38M	3.29M
Selling, General, and Administrative Revenue Growth	+15.69%	+30.90%	+29.37%	-25.13%	+22.97%	-22.03%	+6.27%	-5.13%	+5.94%	+12.45%	-1.83%	+14.18%	+8.18%	-1.60%	+22.00%	+1.05%	+10.89%	+3.57%	+27.47%	+8.41%	-7.71%	+19.67%	+20.68%	+5.79%	+4.19%	-1.98%	+29.58%	+17.10%	+16.85%	-7.77%	-15.19%	-52.16%	+44.52%	+157.77%	-28.24%	+47.63%	+11.55%	-27.46%	n/a
Research and Development Revenue	68.25M	62.08M	79.78M	87.47M	87.53M	86.35M	82.73M	80.57M	72.50M	73.41M	68.30M	75.62M	65.36M	62.12M	55.95M	52.45M	43.05M	49.27M	56.95M	54.24M	41.58M	39.30M	30.91M	27.42M	27.95M	24.55M	19.91M	20.70M	17.75M	19.65M	16.62M	10.90M	8.48M	4.46M	4.19M	5.11M	4.98M	4.06M	2.01M
Research and Development Revenue Growth	+9.92%	-22.18%	-8.79%	-0.06%	+1.37%	+4.37%	+2.68%	+11.13%	-1.23%	+7.48%	-9.68%	+15.70%	+5.21%	+11.03%	+6.67%	+21.84%	-12.63%	-13.48%	+5.00%	+30.44%	+5.81%	+27.16%	+12.72%	-1.89%	+13.83%	+23.30%	-3.79%	+16.58%	-9.67%	+18.23%	+52.49%	+28.53%	+90.03%	+6.46%	-17.92%	+2.49%	+22.86%	+101.67%	n/a